American Society of Hematology (ASH) Congress Review and VTE GuidelinesFebruary 16, 2021 | Oncology Hematology Highlights in Chronic Lymphocytic Leukemia From the 62nd ASH Annual Meeting and Exposition This article presents a review and commentary of selected presentations from the all-virtual 62nd American Society of Hematology (ASH) Meeting and Exposition, which took place in December 2020. Coverage includes safety and efficacy results in trials of acalabrutinib, venetoclax, obinutuzumab, rituximab, LOXO-305, idelalisib, bendamustine, umbralisib, ublituximab, chlorambucil, lisocabtagene maraleucel, and others. Read full article Cardiology ASH 2021 Guidelines for Management of Venous Thromboembolism: Prevention and Treatment in Patients with Cancer These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in their decisions about the prevention and treatment of venous thromboembolism (VTE) – a common complication among patients with cancer who are at a markedly increased risk for morbidity and mortality. Read full article Hematology Highlights in Myelodysplastic Syndromes From the 62nd ASH Annual Meeting and Exposition This article presents a review and commentary of selected presentations from the all-virtual 62nd American Society of Hematology (ASH) Meeting and Exposition, which took place in December 2020. Coverage includes safety and efficacy results from various trials and studies, including MEDALIST, DACOTA, P-2001, M15-531, ACE-536-MF-001, Sintra-REV, and COMMANDS. Read full article
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS